Skip to content
Disclosery

AIHC Capital Management Ltd

Follow

13F filer, CIK 2103725, CENTRAL, Hong Kong

AIHC Capital Management Ltd reported $104,244,027 across 4 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-003381

Period
2026-06-30
Reported value
$104M
Holdings
4
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ORICadded+1,368,909$14.8M
NBPadded+615,100$1.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RVMDreduced-525,841-$98.5M
COGTexited-51,402-$1.98M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001172661-26-003381, largest first. % of portfolio is the value over $104,244,027, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 900,392 shares; 2026Q1: 828,974 shares; 2026Q2: 303,133 shares 303,133$56.8M54.46%-525,841Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 2,459,551 shares; 2026Q2: 3,828,460 shares 3,828,460$41.5M39.77%+1,368,909Timeline
NBPNOVABRIDGE BIOSCIENCESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 413,979 shares; 2026Q1: 2,262,933 shares; 2026Q2: 2,878,033 shares 2,878,033$5.61M5.38%+615,100Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 30,265 shares; 2026Q1: 30,265 shares; 2026Q2: 30,265 shares 30,265$399K0.38%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
COGTCOGENT BIOSCIENCES INC51,402$1.98Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-003381 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001172661-26-003381 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001172661-26-001629 Quarter ended 2026-03-312026-05-08acceptance time not in the bulk data set
13F-HR 0001172661-26-000478 Quarter ended 2025-12-312026-02-05acceptance time not in the bulk data set